Share
Share
Arbor Research Collaborative for Health, a non-profit company focused on conducting health outcomes research, announced the award of a $1.2 Million fixed price contract from the Centers for Disease Control and Prevention (CDC). Healthcare-associated infections (HAIs) are associated with high morbidity and mortality for the more than 1 million persons residing in long-term care facilities (LTCFs), with the CDC having a long-standing commitment for monitoring and reducing HAIs in LTCF residents. Arbor Research will support the National Healthcare Safety Network’s (NHSN) LTCF Component HAI Program through this important step of assessing how well Clostridioides difficile infections, an HAI of public health importance, can be captured in a standardized fashion by EHR systems used by nursing homes across all 10 US Health and Human Services regions.
“Arbor Research continues to expand our work in infectious disease and is looking forward to applying our combined research, policy, and clinical expertise to study the long-term care area, including nursing homes”, says Dr. Christopher Spera, President and CEO of Arbor Research Collaborative for Health.
The Lantana Consulting Group, a company with considerable expertise in developing electronic HAI reporting standards based on Clinical Document Architecture and Fast Healthcare Interoperability Resources will serve as subcontractor for Arbor Research for this study.
“We greatly cherish this opportunity to support the CDC NHSN’s goal to easily, efficiently, and reliably capture HAI-related data for nursing home residents. This will ultimately help reduce reporting burdens for nursing home staff and help facilitate the NHSN’s objective to reduce the incidence of HAIs with the goal of improving health outcomes and quality of life for older adults in long-term care facilities”, says Dr. Ronald Pisoni, Principal Investigator for this study and Distinguished Research Scientist at Arbor Research.
Arbor Research Collaborative for Health is excited to announce a partnership with CSL Vifor to launch a multinational registry designed to capture real-world outcomes of difelikefalin (Kapruvia®), a newly-approved treatment for chronic kidney disease-associated pruritus (CKD-aP) in hemodialysis (HD) patients. Known as PARADIGM (PAn european Registry Addressing pruritus in DIalysis with a focus on Goal […]
The Health Resources and Services Administration (HRSA) has selected Arbor Research Collaborative for Health (Arbor Research) as one of 14 organizations who will lead the modernization of the Organ Procurement and Transplantation Network (OPTN). Arbor Research received one of the five initial efforts, focusing on improving patient safety and policy compliance systems and processes overseen […]
Arbor Research Collaborative for Health (Arbor Research) is proud to announce that its wholly-owned, small-business subsidiary, Arbor Research LLC, received its first competitive prime contract award. The award expands the organization’s 25-year history doing mission-impactful work in chronic disease and beyond. Arbor Research was awarded the National Cancer Institute (NCI) Center for Global Health (CGH) […]
Arbor Research Collaborative for Health, a Michigan-based 501(c)3 nonprofit corporation, is proud to announce the award of the General Services Administration (GSA) Multiple Award Schedule contract to its subsidiary, Arbor Research LLC under SINs 541611 and 541715. Arbor Research LLC qualifies as a small business under the associated NAICS codes and will seek additional SINs […]